Seasoned growth-stage investor and operator focused on technology and healthcare companies. Michael Schupak is known for founding and scaling startups and advising corporates; he evaluates opportunities across SaaS, digital health, and data-driven business models, emphasizing revenue growth, go-to-market execution and capital efficiency. Active in seed-to-growth rounds, provides board-level operational support and strategic capital formation.
Seasoned growth-stage investor and operator focused on technology and healthcare companies. Michael Schupak is known for founding and scaling startups and advising corporates; he evaluates opportunities across SaaS, digital health, and data-driven business models, emphasizing revenue growth, go-to-market execution and capital efficiency. Active in seed-to-growth rounds, provides board-level operational support and strategic capital formation.
Growth-stage oriented investor prioritizing technology and healthcare companies with recurring revenue and data-driven business models. Focuses on SaaS, digital health, and analytics, underwriting opportunities on revenue momentum, scalable go‑to‑market playbooks, unit economics and capital efficiency. Invests across seed to growth rounds, provides board-level operational support and strategic capital formation, favors hands-on partnerships, metric-driven governance, and staged capital deployment to balance rapid scaling with downside protection.
Growth-stage oriented investor prioritizing technology and healthcare companies with recurring revenue and data-driven business models. Focuses on SaaS, digital health, and analytics, underwriting opportunities on revenue momentum, scalable go‑to‑market playbooks, unit economics and capital efficiency. Invests across seed to growth rounds, provides board-level operational support and strategic capital formation, favors hands-on partnerships, metric-driven governance, and staged capital deployment to balance rapid scaling with downside protection.
| Trades 480 | Longs Won 376/480 78% | Profit Factor 17.58 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $409,128.23 |
| Average Win $112,832.39 | Best Trade (Aug 14) $5.72M | Sharpe Ratio -12.86 |
| Average Loss -$23,200.56 | Worst Trade (Mar 30) -$389,270 | Z-Score 23.25 (100%) |
| Commissions $0 | Avg. Trade Length 10m 3d | Expectancy $83,358.58 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 7,937 | 7,143 | 6,349 | 5,556 | 4,762 | 3,968 | 3,175 | 2,381 | 1,587 | 794 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 9,413 | $2.33M | $2.87M | - | $535,658.62 | 22.95% | -1.087% |
ABBV AbbVie Inc. | 932 | $234,464 | $231,108.04 | - | -$3,355.96 | -1.43% | 0.0 |
AMAT Applied Materials, Inc. | 418 | $302,214 | $218,246.16 | - | -$83,967.84 | -27.78% | 0.0 |
AMD Advanced Micro Devices, Inc. | 677 | $393,276 | $317,892.12 | - | -$75,383.88 | -19.17% | 0.0 |
AMZN Amazon.com Inc | 4,147 | $919,253.17 | $1.13M | - | $209,850.52 | 22.83% | -2.093% |
ATRC AtriCure, Inc. | 8,228 | $250,983.39 | $353,392.6 | - | $102,409.21 | 40.8% | +3.146% |
AVDV Avantis International Small Cap Value ETF | 21,308 | $1.39M | $2.33M | - | $944,952.55 | 68.11% | 0.0 |
AVGO Broadcom Inc. | 2,214 | $566,019.11 | $935,193.6 | - | $369,174.49 | 65.22% | 0.0 |
AVIV Avantis International Large Cap Value ETF | 14,900 | $773,310 | $1.23M | - | $458,026 | 59.23% | 0.0 |
BOXX Alpha Architect 1-3 Month Boxx Fund | 53,128 | $6M | $6.26M | - | $261,428.08 | 4.36% | 0.0 |
BRK-B Berkshire Hathaway Inc. | 887 | $413,275.12 | $469,595.54 | - | $56,320.42 | 13.63% | 0.0 |
COST Costco Wholesale Corporation | 233 | $231,070.5 | $221,990.75 | - | -$9,079.75 | -3.93% | 0.0 |
CSCO Cisco Systems, Inc. | 2,289 | $268,913 | $280,562.73 | - | $11,649.73 | 4.33% | 0.0 |
DDOG Datadog, Inc. Class A Common Stock | 1,000 | $260,360 | $260,780 | - | $420 | 0.16% | 0.0 |
DFAC Dimensional U.S. Core Equity 2 ETF | 26,442 | $914,629 | $1.21M | - | $299,323.22 | 32.73% | 0.0 |
DFAE Dimensional Emerging Core Equity Market ETF | 6,230 | $250,527 | $240,914.1 | - | -$9,612.9 | -3.84% | 0.0 |
DFAT Dimensional US Targeted Value ETF | 50,079 | $2.85M | $3.6M | - | $749,497.03 | 26.3% | 0.0 |
DFAX Dimensional World ex U.S. Core Equity 2 ETF | 58,894 | $1.49M | $2.22M | - | $736,544.32 | 49.54% | 0.0 |
DFEM Dimensional Emerging Markets Core Equity 2 ETF | 18,025 | $548,541.29 | $704,957.75 | - | $156,416.46 | 28.51% | 0.0 |
DFEV Dimensional Emerging Markets Value ETF | 86,449 | $2.34M | $3.56M | - | $1.22M | 52.15% | 0.0 |